Then inhibiting angiogenesis via blocking HIF-1α expression may one of the targeting crucial steps in treating hypoxic tumor cells, is expected to provide a novel and attractive target of therapeutic strategies of osteosarcoma. This evidence concerns the gene HIF1A and osteosarcoma.